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Background: The aim of this study was to investigate the influence of the specific inhalation challenge (SIC) on
changes of pH values in exhaled breath condensate (EBC) in patients with hypersensitivity pneumonitis (HP).
Methods: A prospective study of 85 patients with suspected HP, of whom 63 were diagnosed with HP due to
exposure to avian or fungal antigens. In all cases, EBC samples were collected before and after completion of the
SIC and pH values were determined.
Results: Taken as a whole, patients with HP did not present changes in EBC pH after SIC. However, considering
only patients with exposure to molds, those diagnosed with HP had a significantly more acid pH post-SIC than
those with another diagnosis (p = 0.011). This fact is not observed in patients exposed to bird’s antigens. A ROC
curve showed that a reduction in EBC pH of 0.3 units or more after SIC in patients diagnosed with HP due to
exposure to molds had a sensitivity of 30 % (CI: 12.8 to 54.3 %) and a specificity of 100 % (CI: 65.5 to 100 %).
Conclusion: EBC pH may be useful in interpreting SIC results in patients with HP, especially in those patients
exposed to molds. Further studies are now required to test the validity of these proposals.
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Hypersensitivity pneumonitis (HP) is a complex syndrome
of variable intensity and clinical history, caused by an
immune-mediated inflammation of the lung parenchyma
due to the continued inhalation of a wide range of anti-
gens [1]. The increased recognition of exposure to envir-
onmental antigens and improvements in the diagnostic
tools available have allowed the identification of a variety
of environmental and occupational settings that can cause
this disease.
HP is difficult to diagnose because of the wide
spectrum of clinical variants and the absence of a "gold
standard" diagnostic test. In general it is diagnosed on* Correspondence: xmunoz@vhebron.net
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and Cormier’s criteria are the most frequently used
[2]. As HP is an immunologically mediated disease,
some authors have suggested that the specific inhal-
ation challenge (SIC) could be a useful diagnostic tool
[3]. Although the SIC can demonstrate a direct link
between exposure to an antigen and impaired lung
function in the patient [4, 5], its use in the diagnosis
of the HP is limited by the lack of standardization of
both the inhalation protocols and the criteria required
to define a positive response [6, 7]. Thus, while some
authors prioritize the symptoms, others prioritize falls
in forced expiratory volume (FVC) and diffusing cap-
acity of the lung for carbon monoxide (DLCO) to es-
tablish positivity [3].
In view of the inflammatory nature of most respiratory
diseases, the use of non-invasive methods to study lung
function for diagnosing or monitoring these pathologies isticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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sputum cellularity or of biomarkers in exhaled breath or
exhaled breath condensate has proven useful in the evalu-
ation of certain respiratory pathologies [9, 10]. However,
the experience with these techniques in patients with HP
is limited. Some studies using induced sputum have re-
ported an increase in the total cell count and the lympho-
cyte count in patients with HP compared to the healthy
population [11–13]. Also using induced sputum, our
group recently demonstrated that bronchial inflammation
is present in patients with HP, and is mainly evidenced by
increases in neutrophils that worsen following exposure
to the offending antigen during SIC [14]. However,
other non-invasive methods for studying pulmonary in-
flammation have not been analyzed to date in patients
with this disease.
The aim of this study was to investigate the influence
of SIC on changes of pH values in exhaled breath con-




This prospective, cross-sectional study included all pa-
tients older than 18 years, referred to our hospital with
suspected HP between 2005 and 2013 and who under-
went a SIC (Fig. 1). The study was approved by the local
Ethics Committee and all subjects gave informed con-
sent prior to participation (Hospital Vall d’Hebron Ethics
Committee approval PS09/01486).
Diagnostic protocol
Prior to the administration of the SIC, a thorough clin-
ical history was performed along with additional tests:
blood count, immunoglobulin G specific for birds and
fungi [4, 15], blood calcium levels, angiotensin convert-
ing enzyme, lactate dehydrogenase, chest X-ray, high
resolution computed tomography, pulmonary function
tests including spirometry, static lung volumes and carbon
monoxide transfer test, immediate and delayed hypersen-










Fig. 1 Study sample and agents testedlavage and/or transbronchial biopsy and/or criobiopsy. In
all cases the diagnosis was made using Schuyler and
Cormier’s criteria [2]. None of the patients were taking
steroid therapy.
Lung function studies
All patients underwent forced spirometry, static lung
volume study by plethysmography, and determination
of the diffusing capacity of the lung for carbon mon-
oxide (DLCO) using the single breath-hold method.
These studies were performed on a MasterLab system
(MasterLab, Jaegger, Germany) following the joint rec-
ommendations of the European Respiratory Society
and American Thoracic Society [16] and the Spanish
Respiratory Society [17].
Determination of specific IgG antibodies
Specific IgG to avian sera (pigeon, parrot and parakeet),
Aspergillus fumigatus, Penicillium frequentans and Mucor
mucedo were measured by an ELISA technique based on
the method previously described [4, 18]. Wells of high
binding microtiter plates (Costar, Cambridge, MA, USA)
were coated with 2 μg protein/well in 0.1 M Na2CO3/
NaHCO3 buffer (pH 9.6) at 4 °C overnight. The wells were
then washed three times with washing buffer (0.1 M phos-
phate buffered saline, pH 7.5 containing 0.005 % Tween
20) and blocked with 1 % bovine serum albumin in phos-
phate buffered saline for 1 h at 37 °C. The specific IgG as-
says were performed in duplicate by incubating the serum
samples at an appropriate dilution for 2 h at 37 °C, and
wells were washed four times between each step. A solu-
tion of horseradish peroxidase-labeled anti-human IgG
monoclonal antibody (clone MH16-1ME, 0.5 mg/mL) di-
luted at 1:1000 was added to each well and plates were
incubated for 2 h at 37 °C. The reaction was developed
with 3,3’,5,5’-tetramethylbenzidine (Sigma Chemicals), 3 %
H2O2 for 20 min at room temperature in the dark and
stopped with 2 M H2SO4. Optical density at 450 nm was
measured with a microplate reader (Titertek Multiskan
Plus MKII). Results were expressed as absorbance units at
450 nm (A450 nm). Values above the mean plus twod HP
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population of 30 healthy individuals previously studied in
our laboratory were deemed positive.
Bronchoscopy techniques: bronchoalveolar lavage (BAL)
and transbronchial biopsy (TBB)
Bronchoalveolar lavage was performed according to the
recommendations of the European Respiratory Society
[19]. The TBB procedure used has been described by
other authors [20].
Antigen extract preparation for specific inhalation
challenge
Commercialized extracts (Bial-Aristegui, Bilbao, Spain)
from Penicillium frequentans, Aspergillus fumigatus and
Mucor mucedo were used to study fungi [18]. The avian
sera and pigeon bloom extracts were prepared in our la-
boratory, as previously described [3, 18].
Specific inhalation challenge
Informed consent was obtained from all patients prior
to performance of SIC. A de Vilbiss 646 nebulizer
and Mefar MB3 dosimeter were used, which release
the antigenic solution during the first second of each
inhalation. The technique consisted of inhaling 2 mL
of solution at a 1/100 (0.01 mg/mL) dilution. The pa-
tients’ FVC, forced expiratory volume in one second
(FEV1), DLCO and temperature were assessed at baseline,
at 20 min following exposure, and every hour thereafter
for the next eight hours. The SIC was considered positive
according to previously published criteria [3, 18]. In pa-
tients testing negative on SIC, exposure was repeated 24 h
later, at an antigen dilution of 1/10 (0.1 mg/mL). In all
cases a baseline test was performed with placebo solution
the day before inhalation of the putative causal agent.
EBC collection
EBC was collected during tidal breathing with a commer-
cially available condenser (EcoScreen; Jaeger, Würzburg,
Germany), as described elsewhere [9]. Smokers were ad-
vised not to smoke during the 48 h prior to the comple-
tion of SIC. Each EBC sample was divided into 500- μL
aliquots in two to four plastic tubes. Other aliquots were
used to measure the pH before and after deaeration. Base-
line EBC pH was recorded 24 h before the SIC and post-
SIC EBC pH was recorded 24 h after the last antigenic
exposure.
Measurement of pH in EBC
pH was measured in one of the aliquots immediately
after EBC collection and after deaeration with helium
(350 mL/min for 10 min), using a calibrated pH meter
(Model GLP 21; Crison Instruments SA; Barcelona,
Spain) with an accuracy of 0.01 pH, and a probe forsmall volumes (Crison 50 28; Crison Instruments SA).
The probe was calibrated daily with standard pH 7.02
and 4.00 buffers [21].
Statistical analysis
The Mann–Whitney test and chi-square test were ap-
plied to compare continuous and nominal variables, re-
spectively, with a two-sided significance level of 0.05.
The consistency of EBC was estimated by evaluating the
sensitivity (SE) and specificity (SP) [22] of the method,
the positive (PPV) and negative (NPV) predictive values,
and the likelihood ratio of a positive (LR+) and negative
(LR-) value with 95 % confidence intervals (95 % CI)
using the Wilson method [23]. Receiver-operating char-
acteristic (ROC) curves were constructed to determine
the cut-off values that best differentiated between having
the disease or not [24]. All analyses were done with
SPSS, version 17 (Chicago, IL, USA) and, SAS version
9.2 (SAS Institute Inc., Cary, NC, USA).
Results
A total of 99 patients were studied. Fourteen patients
were excluded because the agents suspected of produ-
cing HP were neither birds nor molds (Fig. 1). Of the 85
patients studied, 63 were diagnosed with chronic HP, 42
of whom had been exposed to avian proteins and 21 to
fungal agents. Of these 63 patients, 52 had a positive
SIC. Out of the 52 patients with a positive SIC, 33 were
exposed to bird antigens and 19 to molds [3, 18]. After
SIC, 20 patients presented a decrease of DLCO >20 %,
15 a decrease of FVC between 10 and 15 % plus an in-
crease >0.5 °C in body temperature, 11 a decrease >15 %
in FVC plus a decrease >20 % in DLCO, and finally 6
patients presented a decrease of FVC% >15 %.
Twenty-two patients received diagnoses other than HP,
and in all of them the SIC was negative: five were diagnosed
with nonspecific interstitial pneumonia, five with sarcoid-
osis, eight with bronchiectasis, two with non-classifiable
pulmonary fibrosis and two with idiopathic pulmonary fi-
brosis. Of these 22 patients, 12 were exposed to bird’s anti-
gens and ten to fungi.
The clinical characteristics of the study population are
presented in Table 1. No significant differences in base-
line characteristics were observed according to diagnosis
(HP or non-HP) or exposure to bird’s antigens or molds.
EBC pH values before and after the SIC are displayed
in Fig. 2. The mean reduction in EBC pH after SIC in
patients with HP was 0.02 in those exposed to bird’s an-
tigens and 0.15 in those exposed to molds; it was not
statistically significant in either case (p values 0.903 and
0.634 respectively, Table 2). However, considering only
patients with exposure to molds, those diagnosed with
HP had a significantly more acid pH post-SIC than those
with another diagnosis (p = 0.011) (Fig. 2). In fact, in
Table 1 Demographic data and clinical characteristics of the study subjects
HP Non-HP
n = 63 n = 22
Birds Molds p Birds Molds p
n = 42 n = 21 n = 12 n = 10
Age, mean (SD), years 57 (11.9) 59 (17.91) 0.789 59 (9,42) 58.33 (14.6) 0.892
Sex, M/F 13/29 8/13 0.8 6/6 5/4 0.449
Smoking (%)
Smoker 12.8 10.5 11.1 7
Non-smoker 61.5 52.6 55.6 57
Ex-smoker 25.6 36.8 33.3 36
Crackles, n (%) 22/35 (62,9) 9/14 (64,3) 0,37 6/8(75) 6/8(75) 0,7
Clubbing, n (%) 5/35 (14,3) 0/14 (0) 0,3 2/8(25) 1/8 (12,5) 0,5
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diagnosed with HP than in patients with a different diag-
nosis (p = 0.010).
The sensitivity, specificity and positive and negative
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Fig. 2 EBC pH before and after SIC in patients diagnosed with HP and in tdiagnosis of HP are shown in Table 3. An ROC curve
showed that a reduction of EBC pH of 0.3 units or more
after SIC had a sensitivity of 25 % (CI: 15.9 to 38.7 %)
and a specificity of 81.8 % (CI: 58.9 to 94 %) for the diag-
nosis of HP in the total study population. Analysing onlyBefore SIC After SIC Before SIC After SIC
Fungi HP Fungi exposure
No  HP
p = 0.011
hose with diagnoses other than HP
Table 2 Immunological, functional pulmonary data, and results from BAL and EBC of the study subjects
HP Non-HP
n = 63 n = 22
Birds Molds p Birds Molds p
n = 42 n = 21 n = 12 n = 10
Avian IgG, + / - 22/15 ——— - 5/3 ——— -
Fungal IgG, + / - ——— 11/7 - ——— 2/6 -
FVC %, mean (SD) 74.6 (14.3) 75.53 (12.46) 0.881 75.6 (17.0) 77.33 (12.17) 0.776
DLCO %, mean (SD) 59.5 (17.6) 63.47 (20.33) 0.465 60.3 (15.0) 64.44 (15.89) 0.351
Bronchoscopy (n) 35 17 - 9 9 -
Transbronchial biopsy (n)* 25 13 3 7
Criobiopsy (n)* 4 0 2 1
Bronquial biopsy (n)* 0 0 1 0
Surgical biopsy(n)* 5 0 - 0 0 -
BAL (n) 35 17 - 9 9 -
BAL lymphocytes* % 19.8 (21) 22.41 (17.91) 0.663 20.33 (20.43) 16.1 (11.95) 0.685
SIC, +/− 33/9 19/2 - 0/12 0/10 -
EBC pH before SIC 7.9(0.86)** 7.78(1.03)*** 0.624 8.14(0.52) 7.92(0.67) 0.245
EBC pH after SIC 7.88(0.74)** 7.63(1.02)*** 0.270 8.07(0.56) 8.31 (0.19) 0.273
IgG, immunoglobulin G; FVC, forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; BAL, bronchoalveolar lavage; *Number of patients in
whom the test result was consistent with HP; **p = 0.90; ***p = 0.634
Ojanguren et al. BMC Pulmonary Medicine  (2015) 15:109 Page 5 of 8patients diagnosed with HP due to exposure to fungal
antigens, a fall in EBC pH of 0.3 or greater showed a
sensitivity of 30 % (CI: 12.8 to 54.3 %) and a specificity
of 100 % (CI: 65.5 to 100 %) (Fig. 3). In the group of pa-
tients diagnosed with HP due to exposure to avian pro-
teins, a fall in EBC pH of 0.3 or higher showed a
sensitivity of 23.8 % (CI: 12.6 to 39.8 %) and a specificity
of 66.6 % (35.4 to 88.7 %).Table 3 Exhaled breath condensate diagnostic yield
All Birds Molds
n = 85 n = 54 n = 31
Sensitivity 25.8 23.8 30
% (CI) (15.9-38.7) (12.6-39.8) (12.8-54.3)
Specificity 81.8 66.6 100
% (CI) (58.9-94.0) (35.4-88.7) (65.5-100)
PPV 80 71.4 100
(55.7-93.3) (42.0-90.4) (51.7-100)
NPV 20 0.2 41.6
(6.6-44.2) (0.09-36.1) (22.8-63.0)
PLR 1.42 0.71 —
(0.53-3.79) (0.27-1.87)
NLR 0.9 1.14 0.7
(0.77-1.07) (0.89-1.46) (0.52-0.93)
Data are expressed as % (95 % CI); PPV, positive predictive value; NPV,
negative predictive value; PLR, positive likelihood ratio; NLR, negative
likelihood ratioNo correlation was observed between the EBC pH be-
fore SIC and baseline FVC, DLCO or BAL lymphocytes.
Additionally, no correlation was observed between the
acidification of pH after SIC and fall in FVC, DLCO or
temperature increase.
Considering the false negatives of the SIC, in the group
of patients diagnosed of HP due to molds (n = 2) one pa-
tient experienced a drop in EBC pH> 0.3. In the group of
patients diagnosed of HP due to avian proteins (n = 9),
two patients experienced a drop in EBC pH> 0.3.
Discussion
The present study demonstrates that a drop in EBC
pH of 0.3 or higher after SIC has a sensitivity of
30 % (CI: 12.8 to 54.3 %) and a specificity of 100 %
(CI: 65 5–100 %) for diagnosis of HP due to exposure
to molds. In the case of HP due to bird proteins, a
fall in EBC pH of 0.3 or more after SIC had a sensi-
tivity of 23.8 % (CI: 12.6 to 39.8 %) and a specificity
of 66.6 % (35.4 to 88.7 %). This study is the first to
analyse the diagnostic performance of the EBC pH in
the context of antigen exposure through SIC, in pa-
tients with HP due to exposure to bird’s antigens or
to molds.
These results may be helpful for establishing a firm
diagnosis of HP. In acute forms of the condition the
clinical criteria currently in use are sufficient [2], but es-
tablishing a firm diagnosis in chronic or subacute forms
is much more difficult. It has recently been shown that
up to 50 % of cases of idiopathic pulmonary fibrosis may
ALL MOLDSBIRDS
1 - Specificity 1 - Specificity 1 - Specificity
Fig. 3 ROC curves: assessment of the most relevant difference in EBC pH after SIC in patients with suspected HP
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agnosed [25] and it is in this context where the SIC may
be most useful [26].
The SIC has been used to diagnose since the 1960s,
but there is still no consensus regarding the variables on
which the test’s interpretation should be based. This
situation may influence its sensitivity and specificity. In
a study with 29 patients basically using clinical criteria
such as the onset of symptoms and signs mimicking in-
fluenza, Hendrick et al. [5] reported a sensitivity of up to
85 % and a specificity of 95 %. Also basing positivity on
clinical symptoms, Ohtani et al. [7] found no false re-
sults in a study of 11 patients with bird fancier's lung.
However, other authors using criteria based on falls in
the values obtained in lung function tests reported sensi-
tivities ranging from 82 to 92 % and specificities between
76 and 100 % [4, 6].
Establishing a positive diagnosis from the appearance
of symptoms during the test necessitates a high level of
exposure to the antigen, a requirement which may of
course have a negative effect on the test’s safety. The use
of criteria based on lung function studies to determine
diagnosis may allow lower levels of antigen exposure.
For example, maximum exposure in Ohtani et al.’s [7]
study was 680 μg of avian protein, whereas Morell et al.
[4] used a maximum dose of 200 μg of protein. However,
this lower antigen exposure during SIC may yield false
negatives: evaluating 113 patients, of whom 88 were diag-
nosed with HP due to different agents, Muñoz et al [26]
recently found a sensitivity of 73 % and a specificity of
84 %, and 24 patients finally diagnosed with HP had nega-
tive SIC. The results of this study allow us to hypothesize
that the measurement of EBC pH during SIC may reduce
the number of false negatives and thus improve the test’s
diagnostic accuracy. In this regard, three patients in thepresent study diagnosed with HP but with a negative SIC,
experienced a decline of EBC pH greater than 0.3 units
after the SIC.
EBC pH measurement is a recently introduced tool
which may be useful in assessing various respiratory dis-
eases [27]. Several studies have shown that pH values may
fall in non-controlled asthma [28] or in the context of re-
spiratory infections in patients with bronchiectasis, COPD
or cystic fibrosis [29]. However there is less experience in
the context of interstitial diseases: higher levels have been
found in individuals with pulmonary fibrosis [30], and
lower levels in patients with asbestosis [31]. EBC pH is the
result of a balance between various buffer systems and the
production and release of acids and bases in the airways
[32]. In healthy individuals, EBC is determined to a signifi-
cant extent by the NH4, HCO3 and CO2 produced during
breathing [33], with the most acidic pH being found in the
alveolar lumen in the proximal airway. Inflammatory pro-
cesses trigger a range of mechanisms which produce acid-
ification of these more proximal airways as a possible
innate defense mechanism [34]. These mechanisms are
basically the production and excretion of superoxide ions
and protons by the respiratory epithelial cells, the inhib-
ition of glutaminase activity in epithelial cells, and finally
the recruitment of macrophages and neutrophils whose
lysis in the context of inflammation raises the acidity level
of the environment [35, 36]. In fact the acidification pro-
duced by neutrophil recruitment may well explain some
of the findings of the present study. In this sense, previous
studies have shown that EBC pH values are decreased
during asthma exacerbations but they are not related with
spirometric values [37]. Furthermore Kostikas et al [38]
demonstrated that EBC pH levels are negatively correlated
with the number of eosinophils in sputum and positive
correlated with neutrophilic airway inflammation.
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in the alveoli is characteristic in HP, in the bronchi it
has been shown that there may be neutrophilic inflam-
mation, especially in cases in which molds are the
causative agent [12, 14]. Our group has also recently
confirmed that individuals with HP present significantly
increased levels of neutrophils in induced sputum fol-
lowing the challenge with fungal agents [14]; this may
explain the decrease in pH found in the present study
after the challenge test in patients with HP caused by
molds. Taken together, these findings also allow us to
hypothesize that the mechanism of action of the HP
may differ depending on the causative agent.
This study has a number of limitations, some of
them deriving from factors that may have influenced
the pH values recorded. The most important of these
factors is smoking: lower levels of pH in EBC have
been reported in healthy individuals exposed to to-
bacco smoke than in non-exposed subjects [39, 40]. In
our study, however, this is unlikely to have been a de-
terminant, as we did not find significant differences in
smoking habits in our four study groups. Another
limitation is the small number of patients ultimately
included. Future studies are needed, with larger num-
bers of patients, to confirm the sensitivity and specifi-
city of EBC pH for the diagnosis of HP. Moreover, the
environmental exposure to specific antigens before
SIC is difficult to demonstrate, especially in patients
exposed to molds. If experimental exposure to antigen
can change pH of EBC, natural exposition can also in-
fluence it, so we can not rule out that this environ-
mental exposure might influence the results. Finally,
another possible limitation is the fact that EBC was re-
corded 24 h after the antigen challenge, which may
have affected pH levels observed. As yet, the variabil-
ity of EBC pH after SIC has not been assessed either
in occupational asthma or in HP [41]. In any case, the
decision to record EBC after 24 h was based on the
protocol established by different groups in the context
of occupational asthma, in which markers of inflam-
mation are analysed using noninvasive methods in
order to help establish the positivity of SIC [42].
Conclusions
In conclusion, the results of this study suggest that the use
of EBC pH may be helpful in the interpretation of SIC in
patients with HP. Furthermore, its clinical assessment
in the context of this test in relatively straightforward,
since it is non-invasive, easy to perform, reproducible
and cost-effective. The results of this study also suggest
that the use of EBC pH after SIC can reduce the test’s
false negative rates. Further studies are now required,
with larger numbers of patients, to test the validity of
these proposals.Abbreviations
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